Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.71

-0.8%

1:33 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Elmer who wrote (8928)	8/11/2003 4:40:10 PM
From: Icebrg	of 52153

Elmer Perphas you nephew could discuss the possible use of Zonegran (zonisamide) with his doctor. I remember from the time when I was following Elan more closely, that there appeared to patients who were satisfied with its use. There are of course a number of potential side-effects which some people experience, but not other. One - in this case potentially positive - side-effect is that the drug appears to cause weight loss. Elan has even run some small trials on this theme. You can find the label at fda.gov Please, note that I am not in any way in a position to give or even suggest medical advice. The potential for Zonegran - which is approved for seizures - to induce weight losses, was just a small piece of information, that happened to cross my way. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next